BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16405903)

  • 1. p57Kip2 is induced by MyoD through a p73-dependent pathway.
    Vaccarello G; Figliola R; Cramerotti S; Novelli F; Maione R
    J Mol Biol; 2006 Feb; 356(3):578-88. PubMed ID: 16405903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of p57(KIP2) during muscle differentiation: role of Egr1, Sp1 and DNA hypomethylation.
    Figliola R; Busanello A; Vaccarello G; Maione R
    J Mol Biol; 2008 Jul; 380(2):265-77. PubMed ID: 18513743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MyoD induces the expression of p57Kip2 in cells lacking p21Cip1/Waf1: overlapping and distinct functions of the two cdk inhibitors.
    Figliola R; Maione R
    J Cell Physiol; 2004 Sep; 200(3):468-75. PubMed ID: 15254975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic regulation of p57kip2 by Hes/Hey downstream of Notch signaling and muscle regulatory factors regulates skeletal muscle growth arrest.
    Zalc A; Hayashi S; Auradé F; Bröhl D; Chang T; Mademtzoglou D; Mourikis P; Yao Z; Cao Y; Birchmeier C; Relaix F
    Development; 2014 Jul; 141(14):2780-90. PubMed ID: 25005473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and activity of the CDK inhibitor p57Kip2 in chondrocytes undergoing hypertrophic differentiation.
    Stewart MC; Kadlcek RM; Robbins PD; MacLeod JN; Ballock RT
    J Bone Miner Res; 2004 Jan; 19(1):123-32. PubMed ID: 14753744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma.
    DeYoung MP; Johannessen CM; Leong CO; Faquin W; Rocco JW; Ellisen LW
    Cancer Res; 2006 Oct; 66(19):9362-8. PubMed ID: 17018588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MyoD activity upregulates E2F1 and enhances transcription from the cyclin E promoter in differentiating myoblasts lacking a functional retinoblastoma protein.
    Tedesco D; Vesco C
    Exp Cell Res; 2001 Oct; 269(2):301-11. PubMed ID: 11570822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the cyclin-dependent kinase inhibitor p57Kip2 expression by p63.
    Beretta C; Chiarelli A; Testoni B; Mantovani R; Guerrini L
    Cell Cycle; 2005 Nov; 4(11):1625-31. PubMed ID: 16258268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.
    Andresini O; Rossi MN; Matteini F; Petrai S; Santini T; Maione R
    Epigenetics Chromatin; 2019 Jan; 12(1):8. PubMed ID: 30651140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAp73β-mediated suppression of cell migration requires p57Kip2 control of actin cytoskeleton dynamics.
    Rodhe J; Kavanagh E; Joseph B
    Oncotarget; 2013 Feb; 4(2):289-97. PubMed ID: 23470527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MyoD regulates p57kip2 expression by interacting with a distant cis-element and modifying a higher order chromatin structure.
    Busanello A; Battistelli C; Carbone M; Mostocotto C; Maione R
    Nucleic Acids Res; 2012 Sep; 40(17):8266-75. PubMed ID: 22740650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role of p73 in mitotic exit.
    Merlo P; Fulco M; Costanzo A; Mangiacasale R; Strano S; Blandino G; Taya Y; Lavia P; Levrero M
    J Biol Chem; 2005 Aug; 280(34):30354-60. PubMed ID: 15985436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-specific transcription factors in fibroblasts expressing the alpha-striated tropomyosin 3' untranslated region.
    L'ecuyer TJ; Schutte BC; Mendel KA; Morris E; Fulton AB
    Mol Genet Metab; 1999 Jul; 67(3):213-26. PubMed ID: 10381329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
    Sirri V; Leibovitch MP; Leibovitch SA
    Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.
    Kitzmann M; Fernandez A
    Cell Mol Life Sci; 2001 Apr; 58(4):571-9. PubMed ID: 11361092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-talk between DNA methylation and H3 lysine 9 dimethylation at the KvDMR1 region controls the induction of Cdkn1c in muscle cells.
    Andresini O; Ciotti A; Rossi MN; Battistelli C; Carbone M; Maione R
    Epigenetics; 2016 Nov; 11(11):791-803. PubMed ID: 27611768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation.
    Dhawan J; Helfman DM
    J Cell Sci; 2004 Aug; 117(Pt 17):3735-48. PubMed ID: 15252113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stabilization of MyoD by direct binding to p57(Kip2).
    Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
    J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.